Results 21 to 30 of about 212,304 (319)

Pharmacoeconomic analysis of antineoplastics at the Oncology Institute of Vojvodina from 2005 to 2008 [PDF]

open access: yesArchive of Oncology, 2009
Contemporary cancer chemotherapy need to be active against malignant cell (selectivity), to be based on the molecular biology of the cancer cell, to enhance immune response to cancer, and to stop development of resistance to drug.
Ilić Maja S.
doaj   +1 more source

Can’t Buy Me Rights! The Contractual Structure of Asymmetrical Inter-firm Collaborations [PDF]

open access: yes, 2006
The efficient allocation of control rights in inter-firm collaborations is a widely emphasized issue. In this paper, I empirically identify control rights and the allocation of these rights using a unique survey data set on collaborations between ...
Häussler, Carolin
core   +2 more sources

Pharmacoeconomic analysis of using drugs containing mycophenolic acid in kidney transplant recipients in the context of domestic pharmaceutical market

open access: yesAktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2015
Aim. The use of mycophenolic acid (MPA) in patients after kidney transplantation made it possible to achieve significant results in reducing the number of acute rejection of kidney in recipients, and increasing the long-term survival of transplant ...
V. N. Lesovoy   +2 more
doaj   +1 more source

High growth firms, innovation and competition: the case of the US pharmaceutical industry [PDF]

open access: yes, 2013
Innovation is key to economic growth. But firms, across sectors and regions, are highly skewed in their ability to engage with innovation, and even more skewed in their ability to translate investments in innovation into higher growth.
Mazzucato, Mariana, Parris, Stuart
core   +2 more sources

Cost-consequence analysis of Pharmaceutical Care program for systemic arterial hypertension in the public health system in Brazil

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2018
In Brazil, 80% of hypertensive patients have no blood pressure controlled, this fact has caused severe financial consequences for the public health system (PHS) and the Pharmaceutical Care (PC) has emerged as an effective alternative.
Maurílio de Souza Cazarim   +2 more
doaj   +1 more source

Determinants of real stock return of pharmaceutical products and materials companies

open access: yesSocial Determinants of Health, 2023
Background: The present study aimed to investigate the factors that determine the actual efficiency of pharmaceutical companies. Methods: This study was an applied and descriptive-correlation research.
Hojjatollah Marzban   +2 more
doaj   +1 more source

Authorized Generic Entry prior to Patent Expiry: Reassessing Incentives for Independent Generic Entry [PDF]

open access: yes, 2010
Patent holders frequently attempt to mitigate the loss of monopoly power by authorizing generic entry prior to patent expiry (early entry). Competition in off-patent pharmaceutical markets may be adversely affected if early entry substantially impairs ...
Appelt, Silvia
core   +4 more sources

Five-Year Evaluation of the PROA-NEN Pediatric Antimicrobial Stewardship Program in a Spanish Tertiary Hospital

open access: yesAntibiotics
Introduction: Actions to reduce and optimize antimicrobial use are crucial in the management of infectious diseases to counteract the emergence of short- and long-term resistance.
Aurora Fernández-Polo   +6 more
doaj   +1 more source

Evolving role of pharmaceutical physicians in the industry: Indian perspective

open access: yesPerspectives in Clinical Research, 2012
The Indian pharmaceutical industry, like any other industry, has undergone significant change in the last decade. The role of a Medical advisor has always been of paramount importance in the pharmaceutical companies in India.
Anant Patil, Viraj Rajadhyaksha
doaj   +1 more source

A comparison of self-reported and proxy-reported health utilities in children: a systematic review and meta-analysis

open access: yesHealth and Quality of Life Outcomes, 2021
Objective This study aimed to conduct a systematic review and meta-analysis to compare differences in health utilities (HUs) assessed by self and proxy respondents in children, as well as to evaluate the effects of health conditions, valuation methods ...
Mingyu Jiang   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy